VOTRIENT
Film-coated tablet, 200mg
RxActive license
Active substance (INN)
pazopanib
Pharmaceutical form
Pharmaceutical formFilm-coated tablet
Strength200mg
PackagingUkupno 30 film tableta u bočici plastičnoj u kartonskoj kutiji
ManufacturerGlaxo Wellcome S.A., Spain
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX03)
Marketing authorization holder"NOVARTIS PHARMA SERVICES AG" DIO STRANOG DRUŠTVA PODGORICA
Authorization dateOctober 3, 2025
Analogs in Montenegro
16Other medicines with the same active substance
FRONTIENTRx
Film-coated tablet, 400mgFRONTIENTRx
Film-coated tablet, 200mgLIBURADONERx
Film-coated tablet, 200mgLIBURADONERx
Film-coated tablet, 400mgPARIZOLRx
Film-coated tablet, 400mgPARIZOLRx
Film-coated tablet, 200 mgPAZOPANIB HFRx
Film-coated tablet, 200mgPAZOPANIB HFRx
Film-coated tablet, 200mgPAZOPANIB HFRx
Film-coated tablet, 400mgPAZOPANIB SKRx
Film-coated tablet, 400mgPAZOPANIB SKRx
Film-coated tablet, 200mgPAZOPANIB TEVARestricted
Film-coated tablet, 200mgPAZOPANIB TEVARestricted
Film-coated tablet, 400mgPAZOPANIB ZENTIVARx
Film-coated tablet, 200mgPAZOPANIB ZENTIVARx
Film-coated tablet, 400mgVOTRIENTRx
Film-coated tablet, 400mgSource: CInMED register